Search - tctmd.com

Displaying 1 - 20 of 85

Sort: Relevancy | Date

News Conference News THT 2025

Positive Results With Carillon Mitral Device Seen in Real-world Registries

Todd Neale

February 21, 2025

News Conference News THT 2025

HF Benefits Look Durable in Single-Arm Study of Coronary Sinus Shunt

Todd Neale

February 18, 2025

News Conference News THT 2025

Experts Hash Out Recommendations for Impella CP After DanGer Shock

Todd Neale

February 14, 2025

Presentation THT 2025

Atrial to Coronary Sinus Shunting: Focus on Long Term Effect of RV Structure and Function

Presenter: Ryan Tedford

February 12, 2025

Presentation THT 2025

Interatrial versus Coronary Sinus Shunting: Device and Procedural Comparisons

Presenter: Kamran Muhammad

February 11, 2025

Presentation THT 2025

Left Atrial to Coronary Sinus Shunting in Heart Failure With Mildly Reduced or Preserved Ejection Fraction: The ALT FLOW Trial (Early Feasibility Study) 2-Year Results

Presenter: Javed Butler

February 11, 2025

News Conference News THT 2024

Durable 1-Year Outcomes With Coronary Sinus Shunt for HF: ALT-FLOW EFS

Michael O'Riordan

March 06, 2024

Presentation THT 2024

Shock-Phenotype Matching Using Real-World Evidence: A New Paradigm for Prospective Enrollment in Clinical Trials of Acute MCS Devices in Cardiogenic Shock

Presenter: James W. Schurr

March 06, 2024

Presentation THT 2024

A Novel Study Design, Termed Molecular Triangulation, That Leverages Biologic Similarities Across Seemingly Different Shock Phenotypes In Order to Identify Novel Druggable Targets and Pathophysiologic Mechanisms.

Presenter: Thomas Hanff

March 06, 2024

Presentation THT 2024

DPP3-Based Biotherapy in Cardiogenic Shock

Presenter: Mahir Karakas

March 06, 2024

Presentation THT 2024

Pulsatile ECMO

Presenter: Nader Moazami

March 06, 2024

Presentation THT 2024

Ivabridine in Cardiogenic Shock

Presenter: Maya Guglin

March 06, 2024

Presentation THT 2024

The Conundrum of Clinical Trials in Cardiogenic Shock

Presenter: JoAnn Lindenfeld

March 06, 2024

Presentation THT 2024

Introduction Of Guideline Directed Medical Therapy And Native Heart Recovery In Patients Supported By Impella 5.5

Presenter: Kanika P. Mody

March 06, 2024

Presentation THT 2024

Initial Results from the First-in-Human Study of the Supira System

Presenter: David E. Kandzari

March 06, 2024

Presentation THT 2024

The RECOVER IV Study Overview

Presenter: Navin K. Kapur

March 05, 2024

Presentation THT 2024

Pulmonary Artery Catheter in Shock (PACCS)

Presenter: Shashank Shekhar Sinha

March 05, 2024

Presentation THT 2024

ECMO-Unload: Is This the Answer to ECLS-SHOCK?

Presenter: Dirk Westermann

March 05, 2024

Presentation THT 2024

Inotropes and Mortality in Patients With Cardiogenic Shock Due to Myocardial Infarction: Insights from the SWEDEHEART Registry

Presenter: Elmir Omerovic

March 05, 2024

Presentation THT 2024

PVC-Induced Cardiomyopathy: Ablation Is the Treatment of Choice

Presenter: William Hucker

March 05, 2024

Advertisement

Positive Results With Carillon Mitral Device Seen in Real-world Registries

HF Benefits Look Durable in Single-Arm Study of Coronary Sinus Shunt

Experts Hash Out Recommendations for Impella CP After DanGer Shock

Atrial to Coronary Sinus Shunting: Focus on Long Term Effect of RV Structure and Function

Interatrial versus Coronary Sinus Shunting: Device and Procedural Comparisons

Left Atrial to Coronary Sinus Shunting in Heart Failure With Mildly Reduced or Preserved Ejection Fraction: The ALT FLOW Trial (Early Feasibility Study) 2-Year Results

Durable 1-Year Outcomes With Coronary Sinus Shunt for HF: ALT-FLOW EFS

Shock-Phenotype Matching Using Real-World Evidence: A New Paradigm for Prospective Enrollment in Clinical Trials of Acute MCS Devices in Cardiogenic Shock

A Novel Study Design, Termed Molecular Triangulation, That Leverages Biologic Similarities Across Seemingly Different Shock Phenotypes In Order to Identify Novel Druggable Targets and Pathophysiologic Mechanisms.

DPP3-Based Biotherapy in Cardiogenic Shock

Pulsatile ECMO

Ivabridine in Cardiogenic Shock

The Conundrum of Clinical Trials in Cardiogenic Shock

Introduction Of Guideline Directed Medical Therapy And Native Heart Recovery In Patients Supported By Impella 5.5

Initial Results from the First-in-Human Study of the Supira System

The RECOVER IV Study Overview

Pulmonary Artery Catheter in Shock (PACCS)

ECMO-Unload: Is This the Answer to ECLS-SHOCK?

Inotropes and Mortality in Patients With Cardiogenic Shock Due to Myocardial Infarction: Insights from the SWEDEHEART Registry

PVC-Induced Cardiomyopathy: Ablation Is the Treatment of Choice

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content